New World Pharma (NWP)
Coming soon!
Candlestick trading graphs are not available yet. These types of charts are used by advanced day traders.Metrics
| Price | $2.37 |
| Volatility | |
| 1-year annual return | 136.5% |
| 2-year annual return | 126.4% |
| 5-year annual return | 13.2% |
| Annual return since inception | -3.7% |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
Stock Trading
Traders' Comments
Company Description
World Pharma is a small drug maker constantly seeking to develop new products. The company's research and development arm has discovered a couple successful drugs and pass.it's most popular product is Ossidex, a drug that helps people with obsessive-compulsive behaviors cure every everyday pains, such as the irrational urge to check lock doors repetitively.
The company is based out of London, UK, with its main research facility in Zurich, Switzerland. It was founded in 1994 by Gordon Helmut, a Nobel prize winning scientist who holds 7 PhD's.
The company stock is extremely volatile, as the drug development process is very long and uncertain. Many drugs do not make it through the approval process, and need to be written off as severe losses. On the other hand, successful patent application congealed years of monopolistic profits with the drug.
Company News
-
Gullibex Approved for Worldwide Sale
NWP's newest drug has passed all tests will flying colors, and is now ready to be marketed.
Stock price reaction: ▲325% -
New Drug in Approval Stage
New World Pharma has discovered a new drug to treat gullibility. Initial clinical trials showed that the drug worked significantly in 78% of patients. The company is currently awaiting for government approval to start selling the drug. The decision is expected in the 1-4 weeks.
Stock price reaction: ▲30%